Dr Reddy's get U.S. nod for blood pressure tablets

If you missed our coverage, here are the top 10 stories of the day

A Dreamliner in Air India colours at an airport in Washington

U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.

Shares of the company were up 1.51 percent at Rs 1,671.

U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.

Shares of the company were up 1.51 percent at Rs 1,671.

Copyright Thomson Reuters 2012

lock-gif
Register for Free
to continue reading
Sign Up with Google
OR
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google
Google Badge